Shinichiro Nakano is a student of the LL.M. in National and Global Health Law and a member of the class of 2023. He is originally from Japan.
Nakano is interested in the law and regulation of drugs, biologics, medical devices, and healthy food, as well as in assisted reproductive technology and CRISPER technology.
Prior to enrolling at Georgetown Law, Nakano served as a member of Healthcare Practice Group at Mori Hamada & Matsumoto. He previously advised both domestic and foreign companies on Japanese regulations on products, such as pharmaceutical, medical devices, and tobacco. He also has experience reviewing the risks and regulatory overview of assisted reproductive technologies. In addition, he is a member of the dispute resolution team and has represented many companies in disputes, such as medical device product liability litigation, medical device recall dispute, joint research and development dispute for new drug, and medical malpractice litigation. He is currently a research assistant at the O’Neill Institute.
Nakano holds a LL.B. from the University of Tokyo and was recognized as a “Very Good Scholar” in his primary field of study, positive law. He has also passed the Preliminary Bar Examination and the National Bar Examination while in the University of Tokyo, School of Law.
He has also completed his legal training at the Legal Training and Research Institute of the Supreme Court of Japan, is admitted to the Daini Tokyo Bar Association, and is registered by the Japan Federation of Bar Associations as an attorney-at-law in Japan.